We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Malaria Biomarkers Detected In Human Breath

By LabMedica International staff writers
Posted on 13 Apr 2015
The majority of diagnoses of malaria rely on a combination of clinical presentation and visualizing parasites in a stained blood film or by performing a rapid diagnostic test.

Human breath offers an attractive alternative to blood as the basis for simple, non-invasive diagnosis of infectious disease, and when breath samples were taken during controlled human malaria infection specific malaria associated volatiles could be detected in human breath.

Scientists at the Commonwealth Scientific and Industrial Research Organization (CSIRO) (Dickson, Australia) and their colleagues collected breath samples from volunteers that had been infected with the malaria parasite Plasmodium falciparum, who were enrolled in a drug trial. More...
The volunteers breathed through a cardboard tube into a chamber connected to a connected to a 3‐L impermeable aluminum gas bag (Shanghai Sunrise Instrument Co.; Shanghai, China).

Exhaled breath analysis was carried out by gas chromatography-mass spectrometry. The gas chromatograph 451 Model GC (Bruker Daltonik Inc.; Billerica, MA, USA) was used and the Bruker Daltonik Scion SQ single quadrupole mass was set with a full scan detection. Real-time polymerase chain reactions and cell cultures were also performed.

The team identified nine compounds whose concentrations varied significantly over the course of malaria infection: carbon dioxide, isoprene, acetone, benzene, cyclohexanone and four thioethers. The latter group: allyl methyl sulfide, 1-methylthio-propane, (Z)-1-methylthio-1-propene and (E)-1-methylthio-1-propene had not previously been associated with any disease condition.

Before antimalarial-drug treatment, there was evidence of concurrent 48 hour-cyclical changes in both the levels of thioethers and parasitemia. Phase-shifting the values for thioether concentrations by 24 hours, revealed a direct correlation between the parasitemia and volatile levels. Volatile levels declined monotonically at around 6.5 hours after initial drug treatment, correlating with clearance of parasitemia. The study was published online on March 25, 2015, in the Journal of Infectious Diseases.

Related Links:
Commonwealth Scientific and Industrial Research Organization
Shanghai Sunrise Instrument Co.
Bruker Daltonik Inc.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Automated Immunoassay Analyzer
SuperFlex™
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Shutterstock

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes

Secondary prevention after myocardial infarction or stroke relies on antiplatelet therapy, yet responses vary widely and both recurrent thrombosis and bleeding remain persistent risks. In the United Kingdom,... Read more

Molecular Diagnostics

view channel
Image: The Avantect Pancreatic Cancer Test combines epigenomic, genomic, and glycan biomarkers with machine learning to detect pancreatic cancer-associated signals in blood (Photo courtesy of ClearNote Health)

Multiomic Blood Test Supports Noninvasive Monitoring and Subtyping in Pancreatic Cancer

Pancreatic ductal adenocarcinoma remains difficult to detect early and monitor during treatment, particularly in patients with homologous recombination defects. Clinicians also have limited noninvasive... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image Credit: Adobe Stock

Mayo Clinic and Thermo Fisher Launch Multi-Omics Venture to Identify Early Disease Signals

Many diseases begin developing years before symptoms emerge, making early detection difficult for healthcare systems and clinical laboratories. Linking molecular changes with longitudinal health data could... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.